Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

65
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
65
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

36
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
36
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31
Hyperglycemia01:29

Hyperglycemia

34
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
34
Diabetic Nephropathy01:28

Diabetic Nephropathy

49
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49
Regulation of Water Intake01:25

Regulation of Water Intake

2.2K
Osmolality refers to the number of solute particles per kilogram of solvent in a solution. Plasma osmolality specifically indicates the total number of solute particles per kilogram of water in blood plasma. This value reflects the body's hydration status and is tightly regulated through mechanisms controlling water intake and output. While water consumption is a conscious decision, the body has intrinsic regulatory systems to maintain fluid balance. Dehydration, a state of water deficit...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Communications medicine·2026
Same author

Cindynics is de rigueur in laboratories and hospital units<sup>✰</sup>.

Presse medicale (Paris, France : 1983)·2026
Same author

Pubertal Dynamics of Sertoli and Leydig Cell Dysfunction in Klinefelter Syndrome.

Clinical endocrinology·2026
Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026
Same author

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Related Experiment Video

Updated: May 5, 2026

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
04:41

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Published on: July 25, 2025

1.2K

Diabetes insipidus.

Clara Leroy1, Wassila Karrouz, Claire Douillard

  • 1Service d'endocrinologie et maladies métaboliques, centre hospitalier régional universitaire de Lille (CHRU de LIlle), hôpital Huriez/Inserm U 859, 1, rue Polonovski, 59000 Lille, France.

Annales D'Endocrinologie
|November 30, 2013
PubMed
Summary
This summary is machine-generated.

Diabetes insipidus (DI) is a disorder of water balance characterized by excessive thirst and urination. Diagnosis involves medical history, physical exams, and tests like MRI and desmopressin challenges to identify the cause and guide treatment.

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.3K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.7K

Related Experiment Videos

Last Updated: May 5, 2026

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas
04:41

Glucose-Stimulated Insulin Secretion via Perfusion through the Mice Vasculature with an Intact Pancreas

Published on: July 25, 2025

1.2K
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.3K
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

11.7K

Area of Science:

  • Endocrinology
  • Nephrology
  • Genetics

Background:

  • Diabetes insipidus (DI) is defined by polyuria exceeding 3 liters/24 hours, even during water deprivation.
  • Causes include defects in arginine-vasopressin (AVP) synthesis (central DI), AVP resistance (nephrogenic DI), abnormal thirst regulation, or gestational DI.
  • Thorough medical history and physical examination are crucial for initial assessment.

Purpose of the Study:

  • To outline the diagnostic approach for diabetes insipidus.
  • To highlight key investigations for differentiating DI subtypes.
  • To discuss recent advances in etiological work-up and potential targeted therapies.

Main Methods:

  • Detailed patient history, including onset, duration, medications, and family history.
  • Physical examination focusing on hydration status, blood pressure, and signs of underlying conditions.
  • Laboratory tests (serum/urine osmolality, electrolytes), water deprivation test, desmopressin test, and pituitary MRI.

Main Results:

  • Severe DI shows urine osmolality < 250 mOsmol/kg and serum sodium > 145 mmol/L.
  • Partial DI diagnosis is aided by water deprivation tests and vasopressin/copeptin levels.
  • Pituitary MRI can reveal posterior pituitary signal changes and identify structural lesions, aiding differentiation from primary polydipsia.

Conclusions:

  • Accurate diagnosis of DI relies on a combination of clinical evaluation, biological assessments, and imaging.
  • Understanding the etiology, including genetic factors and IgG4-related hypophysitis, is key for future targeted therapies.
  • DI can result from various conditions, including head trauma and pituitary surgery.